Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-09

Clinical Trial Update: An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine

View source ↗

Summary

An observational study evaluating BOTOX® for prevention of chronic migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Status: COMPLETED | Results posted: 2018-11-09